Dolby Laboratories (DLB) Stock Forecast & Price Target

Dolby Laboratories is well positioned because its premium Atmos, Vision, and patent licensing mix is expanding faster than the foundational device-driven business, with that segment expected to grow 15% to 20% and already approaching 50% of license revenue from 23% in FY21. Its dominant market position, wide OEM adoption across 4K TVs, smartphones, tablets, PCs, and over 40 auto OEMs across 140 models support rising royalty per device and more recurring, less shipment-dependent revenue streams through VDP and OptiView. Even with macro headwinds and softer device volumes, the company is generating strong cash, supporting a $1.44 annual dividend, repurchases, and the potential for high-single-digit revenue growth as adoption broadens.

Dolby Laboratories is viewed negatively because its revenue is highly exposed to the timing of customer device shipments, and supply chain interruptions can make forecasting more difficult while limiting management’s visibility. Semiconductor shortages are a particularly important risk because they can inhibit Dolby’s ability to attach its technology to new devices, directly pressuring licensing and related revenue. Governance also adds concern, as as of the end of September 2022 the Dolby family and affiliates controlled 84% of voting power through Class B shares, which can reduce minority shareholder influence and accountability.